Financials in USD. Standardized financial statements.
A compact view of how Emergent Health Corp turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2013 | FY 2012 |
|---|---|---|---|---|---|---|---|
| Revenue? | $1.64M | $574,613 | $119,567 | $167,191 | $183,120 | $989,835 | $1,365.753 |
| Revenue Growth? | +184.5% | +380.6% | -28.5% | -8.7% | -81.5% | +72375.4% | 0.0% |
| Cost of Revenue? | $596,872 | $446,974 | $60,090 | $45,770 | $54,466 | $260,794 | $563.453 |
| Gross Profit? | $1.04M | $127,639 | $59,477 | $121,421 | $128,654 | $729,041 | $802.3 |
| Gross Margin? | +63.5% | +22.2% | +49.7% | +72.6% | +70.3% | +73.7% | +58.7% |
| Operating Expenses? | $2.45M | $1.88M | $259,048 | $201,161 | $187,394 | $539,855 | $576.834 |
| Operating Income? | -$1.41M | -$1.76M | -$199,570 | -$79,740 | -$58,740 | $189,190 | $225.466 |
| EBITDA? | -$1.39M | -$1.73M | -$179,571 | -$55,983 | -$48,740 | $189,538 | $225.818 |
| Income Before Tax | -$1.63M | -$2.11M | -$289,847 | -$79,740 | -$68,569 | $191,027 | $211.64 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $70,000 | $80 |
| Net Income? | -$1.63M | -$2.11M | -$288,764 | -$79,125 | -$67,498 | $121,027 | $131.64 |
| EPS? | $-0.00 | $-0.01 | $-0.01 | $-0.00 | $-0.00 | $0.00 | $0.01 |
| Diluted EPS? | $-0.00 | $-0.01 | $-0.01 | $-0.00 | $-0.00 | $0.00 | $0.01 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality